Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward
Brain · 2024
DOI: 10.1093/brain/awae168 ↗Kurz gefasst
Kommentar in der Zeitschrift Brain, 2024. Verfasst von Alexander J Cammack und 2 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute at UCL, London, WC1E 6BT, UK. Hauptthemen laut MEDLINE: C9orf72 Protein, Oligonucleotides, Antisense, Proteins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Live Like Lou, Academy of Medical Sciences Starter, Clinical Lecturers.
Abstract (Originalsprache)
The recent failure of two independent clinical trials targeting C9orf72 sense repeat-containing RNAs with antisense oligonucleotides was a great disappointment for the field. Cammack et al. discuss the data from these trials, possible reasons for the failures, and the future of C9orf72 therapeutic targeting moving forward.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.
- Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
ORCID-Profile: Adrian M Isaacs
Förderung
- Live Like Lou
- Academy of Medical Sciences Starter
- Clinical Lecturers
- UK Dementia Research Institute
- Medical Research Council
- LifeArc
- Alzheimer's Research UK
- Alzheimer’s Research UK
Zitieren
APA
Cammack, A. J., Balendra, R., & Isaacs, A. M. (2024). Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward. Brain. https://doi.org/10.1093/brain/awae168
Vancouver
Cammack AJ, Balendra R, Isaacs AM. Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward. Brain. 2024. doi:10.1093/brain/awae168
BibTeX
@article{Cammack2024,
author = {Cammack, Alexander J and Balendra, Rubika and Isaacs, Adrian M},
title = {Failure of C9orf72 sense repeat-targeting antisense oligonucleotides: lessons learned and the path forward},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae168}
}
EUVIMED